Lappin D - Search Results

1

Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.

Dolan V, Murphy M, Sadlier D, Lappin D, Doran P, Godson C, Martin F, O'Meara Y, Schmid H, Henger A, Kretzler M, Droguett A, Mezzano S, Brady HR. Dolan V, et al. Among authors: lappin d. Am J Kidney Dis. 2005 Jun;45(6):1034-9. doi: 10.1053/j.ajkd.2005.03.014. Am J Kidney Dis. 2005. PMID: 15957132

2

Gremlins: is this what renal fibrogenesis has come to?

Murphy M, McMahon R, Lappin DW, Brady HR. Murphy M, et al. Exp Nephrol. 2002;10(4):241-4. doi: 10.1159/000063698. Exp Nephrol. 2002. PMID: 12097827 Review.

3

Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy.

Lappin DW, McMahon R, Murphy M, Brady HR. Lappin DW, et al. Nephrol Dial Transplant. 2002;17 Suppl 9:65-7. doi: 10.1093/ndt/17.suppl_9.65. Nephrol Dial Transplant. 2002. PMID: 12386293 Review.

4

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.

Higgins DF, Lappin DW, Kieran NE, Anders HJ, Watson RW, Strutz F, Schlondorff D, Haase VH, Fitzpatrick JM, Godson C, Brady HR. Higgins DF, et al. Among authors: lappin dw. Kidney Int. 2003 Dec;64(6):2079-91. doi: 10.1046/j.1523-1755.2003.00306.x. Kidney Int. 2003. PMID: 14633130 Free article.

5

Gremlins, glomeruli and diabetic nephropathy.

Lappin DW, Hensey C, McMahon R, Godson C, Brady HR. Lappin DW, et al. Curr Opin Nephrol Hypertens. 2000 Sep;9(5):469-72. doi: 10.1097/00041552-200009000-00002. Curr Opin Nephrol Hypertens. 2000. PMID: 10990363 Review.

6

Gene responses to hyperglycaemia.

Lappin DW, Doran P, Godson C, Brady HR. Lappin DW, et al. Exp Nephrol. 2002;10(2):120-9. doi: 10.1159/000049907. Exp Nephrol. 2002. PMID: 11937759 Review.

7

Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

Baelde HJ, Eikmans M, Doran PP, Lappin DW, de Heer E, Bruijn JA. Baelde HJ, et al. Am J Kidney Dis. 2004 Apr;43(4):636-50. doi: 10.1053/j.ajkd.2003.12.028. Am J Kidney Dis. 2004. PMID: 15042541

8

Biphasic regulation of leukocyte trafficking by lipoxins.

Stenson C, Mitchell S, Lappin D, Brady HR, Godson C. Stenson C, et al. Among authors: lappin d. Adv Exp Med Biol. 2002;507:543-9. doi: 10.1007/978-1-4615-0193-0_83. Adv Exp Med Biol. 2002. PMID: 12664638 Review. No abstract available.

9

15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.

Leonard MO, Hannan K, Burne MJ, Lappin DW, Doran P, Coleman P, Stenson C, Taylor CT, Daniels F, Godson C, Petasis NA, Rabb H, Brady HR. Leonard MO, et al. J Am Soc Nephrol. 2002 Jun;13(6):1657-62. doi: 10.1097/01.asn.0000015795.74094.91. J Am Soc Nephrol. 2002. PMID: 12039996

10

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

Baelde HJ, Eikmans M, Lappin DW, Doran PP, Hohenadel D, Brinkkoetter PT, van der Woude FJ, Waldherr R, Rabelink TJ, de Heer E, Bruijn JA. Baelde HJ, et al. Among authors: lappin dw. Kidney Int. 2007 Apr;71(7):637-45. doi: 10.1038/sj.ki.5002101. Epub 2007 Jan 31. Kidney Int. 2007. PMID: 17264876 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page